Sorrento Therapeutics Inc (SRNE): The dynamite Brazil study is NCT04528667...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	2
Posts	46
Boards Moderated	0
Alias Born	02/18/2013

PHAN

Re: dia76ca post# 8296

Thursday, 02/04/2021 12:04:37 PM

Thursday, February 04, 2021 12:04:37 PM

The dynamite Brazil study is NCT04528667, updated as "Recruiting" Feb 1, 2021. This is for STI-5656 or Abivertnib Maleate, oral capsules. The great news is this is a 7 day treatment and of the 400 participants, 3 to 1 patients will receive the 5656 vs. placebo.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM